Parasympathomimetic drug
This article needs additional citations for verification. (December 2013) |
A parasympathomimetic drug, sometimes called a cholinomimetic drug
Some
fall into this category.Structure activity relationships for parasympathomimetic drugs[7]
For a cholinergic agent, the following criteria describe the structure activity relationship:
- Ing's Rule of 5: there should be no more than five atoms between the nitrogen and the terminal hydrogen for muscarinic (or cholinergic) activity;
- the molecule must possess a nitrogen atom capable of bearing a positive charge, preferably a quaternary ammonium salt;
- for maximum potency, the size of the alkyl groups substituted on the nitrogen should not exceed the size of a methyl group;
- the molecule should have an oxygen atom, preferably an ester-like oxygen capable of participating in a hydrogen bond;
- there should be a two-carbon unit between the oxygen atom and the nitrogen atom.
Pharmaceuticals/Supplements
Direct-acting
These act by stimulating the nicotinic or muscarinic receptors.
- Choline esters
- acetylcholine receptors)
- M3 receptors)
- nicotinic receptors)
- muscarinic receptors)
- Plant alkaloids
Indirect-acting
Indirect acting parasympathomimetic substances may be either reversible cholinesterase inhibitors, irreversible cholinesterase inhibitors or substances that promote ACh release or
- Reversible cholinesterase inhibitors
- Donepezil
- Edrophonium
- Neostigmine
- Physostigmine
- Pyridostigmine
- Rivastigmine
- Tacrine
- Caffeine (non-competitive)[8]
- Huperzine A
- Irreversible cholinesterase inhibitors
- Echothiophate
- Isoflurophate
- Malathion
- ACh release promoters
- Anti-adrenergics: See also alpha blocker and beta blocker
- α1, giving negative feedback)
- Methyldopa (α2 agonist, giving negative feedback)
- β-receptor antagonist)
- β-receptor antagonist)
- Atenolol (β1 antagonist)
- Prazosin (α1 antagonist)
- Oxymetazoline (partial α2 adrenergic agonist)
See also
- Sympathomimetic drug
- Parasympatholytics
- sympatholytics
References
- ^ OCLC 958121223.
- ^ ISBN 978-0-7020-5554-6.
Parasympathomimetics are a group of drugs that act either by directly stimulating the muscarinic receptor, for example pilocarpine, or by inhibiting the enzyme acetylcholinesterase, which hydrolyses the acetylcholine in the synapse.
- ^ "Dorlands Medical Dictionary:parasympathomimetic". Archived from the original on 2009-07-26.
- ^ Parasympathomimetics
- ISBN 0-7216-7757-6
- S2CID 244530010.
- ^ "Medicinal Chemistry of Adrenergics and Cholinergics". Archived from the original on 2010-11-04. Retrieved 2010-10-23.
- PMID 2003276.
External links
- Parasympathomimetics at the U.S. National Library of Medicine Medical Subject Headings (MeSH)